Warrants Finder
Your selection:
898 Results
| GW9FEZ | Regeneron Pharmaceuticals Inc./OS/Call [630]/GOLDS | - | - | 630.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.038% | 0.684 | -0.009 | 2.666 | 01/21/2028 | 0.010 | Goldman Sachs | ||
| GW9CYX | Regeneron Pharmaceuticals Inc./OS/Call [640]/GOLDS | - | - | 640.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.129% | 0.673 | -0.009 | 2.692 | 01/21/2028 | 0.010 | Goldman Sachs | ||
| GW9CYY | Regeneron Pharmaceuticals Inc./OS/Call [640]/GOLDS | - | - | 640.000 | call | Regeneron Pharmaceuticals Inc. | - | 44.315% | 0.684 | -0.008 | 2.409 | 06/16/2028 | 0.010 | Goldman Sachs | ||
| GW9D0L | Regeneron Pharmaceuticals Inc./OS/Call [640]/GOLDS | - | - | 640.000 | call | Regeneron Pharmaceuticals Inc. | - | 40.702% | 0.661 | -0.011 | 3.430 | 06/17/2027 | 0.010 | Goldman Sachs | ||
| JF9RFX | Regeneron Pharmaceuticals Inc./OS/Call [640]/JPM | - | - | 640.000 | call | Regeneron Pharmaceuticals Inc. | - | 38.165% | 0.658 | -0.015 | 4.995 | 12/18/2026 | 0.010 | JP Morgan | ||
| JH48W9 | Regeneron Pharmaceuticals Inc./OS/Call [640]/JPM | - | - | 640.000 | call | Regeneron Pharmaceuticals Inc. | - | 37.499% | 0.679 | -0.022 | 7.433 | 09/18/2026 | 0.010 | JP Morgan | ||
| JE9D3K | Regeneron Pharmaceuticals Inc./OS/Call [640]/JPMD | - | - | 640.000 | call | Regeneron Pharmaceuticals Inc. | - | 37.864% | 0.657 | -0.014 | 4.685 | 01/15/2027 | 0.010 | JP Morgan | ||
| JE9D5Q | Regeneron Pharmaceuticals Inc./OS/Call [640]/JPMD | - | - | 640.000 | call | Regeneron Pharmaceuticals Inc. | - | 40.784% | 0.654 | -0.013 | 3.908 | 03/19/2027 | 0.010 | JP Morgan | ||
| JY1K0P | Regeneron Pharmaceuticals Inc./OS/Call [640]/JPMD | - | - | 640.000 | call | Regeneron Pharmaceuticals Inc. | - | 40.565% | 0.700 | -0.031 | 9.008 | 08/21/2026 | 0.010 | JP Morgan | ||
| PG10X0 |  | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 40.109% | 0.632 | -0.016 | 4.930 | 12/18/2026 | 0.010 | BNP Paribas | |
| PG10X5 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 39.999% | 0.635 | -0.015 | 4.588 | 01/15/2027 | 0.010 | BNP Paribas | |
| PG10XH | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 39.287% | 0.642 | -0.024 | 7.455 | 09/18/2026 | 0.010 | BNP Paribas | |
| PJ912P | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 40.684% | 0.638 | -0.013 | 3.982 | 03/19/2027 | 0.010 | BNP Paribas | |
| PK0118 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 45.520% | 0.662 | -0.009 | 2.685 | 12/17/2027 | 0.010 | BNP Paribas | |
| PM3TMA | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 42.627% | 0.647 | -0.011 | 3.361 | 06/17/2027 | 0.010 | BNP Paribas | |
| PM3TMC | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 45.698% | 0.665 | -0.009 | 2.608 | 01/21/2028 | 0.010 | BNP Paribas | |
| PM3TMD | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 45.953% | 0.671 | -0.009 | 2.500 | 03/17/2028 | 0.010 | BNP Paribas | |
| PM3TME | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 46.843% | 0.679 | -0.008 | 2.337 | 06/16/2028 | 0.010 | BNP Paribas | |
| GW1T95 | Regeneron Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.124% | 0.663 | -0.009 | 2.722 | 01/21/2028 | 0.010 | Goldman Sachs | ||
| GW3WD7 | Regeneron Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 37.682% | 0.635 | -0.014 | 4.819 | 01/15/2027 | 0.010 | Goldman Sachs | ||
| GW4K3R | Regeneron Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 38.567% | 0.639 | -0.012 | 4.156 | 03/19/2027 | 0.010 | Goldman Sachs | ||
| GW92PH | Regeneron Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.503% | 0.674 | -0.008 | 2.463 | 06/16/2028 | 0.010 | Goldman Sachs | ||
| GW92TJ | Regeneron Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 40.045% | 0.645 | -0.011 | 3.528 | 06/17/2027 | 0.010 | Goldman Sachs | ||
| GW92TM | Regeneron Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 35.528% | 0.645 | -0.022 | 8.124 | 09/18/2026 | 0.010 | Goldman Sachs | ||
| GN0FY1 | Regeneron Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | 750.000 | - | - | - | - | 09/18/2026 | 0.100 | Goldman Sachs | ||
| JF9RFZ | Regeneron Pharmaceuticals Inc./OS/Call [650]/JPM | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 37.590% | 0.633 | -0.015 | 5.203 | 12/18/2026 | 0.010 | JP Morgan | ||
| JH48WB | Regeneron Pharmaceuticals Inc./OS/Call [650]/JPM | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 36.313% | 0.646 | -0.022 | 7.964 | 09/18/2026 | 0.010 | JP Morgan | ||
| MK21H9 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 41.167% | 0.630 | -0.016 | 4.838 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MK9KFD | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 43.238% | 0.646 | -0.011 | 3.327 | 06/17/2027 | 0.010 | Morgan Stanley | |
| MM5GYT | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 42.390% | 0.632 | -0.026 | 7.049 | 09/18/2026 | 0.010 | Morgan Stanley | |
| MN1W1T | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | 700.000 | - | - | - | - | 09/18/2026 | 0.100 | Morgan Stanley | |
| MN8XD9 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | 700.000 | - | - | - | - | 11/20/2026 | 0.100 | Morgan Stanley | |
| MN8XDA | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | 700.000 | - | - | - | - | 12/18/2026 | 0.100 | Morgan Stanley | |
| MN8XD8 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | 700.000 | 5.222% | - | - | - | 03/19/2027 | 0.100 | Morgan Stanley | |
| MN9V78 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 41.541% | 0.637 | -0.013 | 3.925 | 03/19/2027 | 0.010 | Morgan Stanley | |
| MR03TD | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 48.061% | 0.663 | -0.010 | 2.583 | 12/17/2027 | 0.010 | Morgan Stanley | |
| MR3CEZ | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 53.997% | 0.688 | -0.009 | 2.120 | 06/16/2028 | 0.010 | Morgan Stanley | |
| MR3SHJ | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | 700.000 | 5.248% | - | - | - | 01/15/2027 | 0.100 | Morgan Stanley | |
| MR3SQ4 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | 700.000 | 5.230% | - | - | - | 06/17/2027 | 0.100 | Morgan Stanley | |
| FA6MCU | Regeneron Pharmaceuticals Inc./OS/Call [650]/SOC | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 38.722% | 0.640 | -0.235 | 7.565 | 09/18/2026 | 0.100 | Société Générale | ||
| FA6MCW | Regeneron Pharmaceuticals Inc./OS/Call [650]/SOC | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 38.789% | 0.631 | -0.153 | 5.076 | 12/18/2026 | 0.100 | Société Générale | ||
| FD5FE3 | Regeneron Pharmaceuticals Inc./OS/Call [650]/SOC | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 39.593% | 0.636 | -0.124 | 4.079 | 03/19/2027 | 0.100 | Société Générale | ||
| VY416D | | Regeneron Pharmaceuticals Inc./OS/Call [650]/VONT | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 39.041% | 0.634 | -0.014 | 4.687 | 01/15/2027 | 0.010 | Vontobel | |
| VY419S | | Regeneron Pharmaceuticals Inc./OS/Call [650]/VONT | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 42.718% | 0.650 | -0.035 | 9.159 | 08/21/2026 | 0.010 | Vontobel | |
| VY42D5 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/VONT | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 39.725% | 0.631 | -0.016 | 4.978 | 12/18/2026 | 0.010 | Vontobel | |
| VY5LQ6 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/VONT | - | - | 650.000 | call | Regeneron Pharmaceuticals Inc. | - | 37.189% | 0.643 | -0.022 | 7.759 | 09/18/2026 | 0.010 | Vontobel | |
| GW0VJM | Regeneron Pharmaceuticals Inc./OS/Call [660]/GOLDS | - | - | 660.000 | call | Regeneron Pharmaceuticals Inc. | - | 41.368% | 0.632 | -0.011 | 3.494 | 06/17/2027 | 0.010 | Goldman Sachs | ||
| GW0VKX | Regeneron Pharmaceuticals Inc./OS/Call [660]/GOLDS | - | - | 660.000 | call | Regeneron Pharmaceuticals Inc. | - | 38.375% | 0.619 | -0.012 | 4.261 | 03/19/2027 | 0.010 | Goldman Sachs | ||
| GW0VL0 | Regeneron Pharmaceuticals Inc./OS/Call [660]/GOLDS | - | - | 660.000 | call | Regeneron Pharmaceuticals Inc. | - | 37.344% | 0.614 | -0.014 | 4.974 | 01/15/2027 | 0.010 | Goldman Sachs | ||
| GW1J1F | Regeneron Pharmaceuticals Inc./OS/Call [660]/GOLDS | - | - | 660.000 | call | Regeneron Pharmaceuticals Inc. | - | 42.363% | 0.648 | -0.009 | 2.863 | 12/17/2027 | 0.010 | Goldman Sachs |